ProQR Therapeutics NV (NASDAQ:PRQR)

0.668
Delayed Data
As of 4:00pm ET
 +0.0258 / +4.02%
Today’s Change
0.53
Today|||52-Week Range
9.09
-91.66%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 2.00, with a high estimate of 5.00 and a low estimate of 0.96. The median estimate represents a +199.54% increase from the last price of 0.67.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in ProQR Therapeutics NV. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$897.1K
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.21%
 
 
 
 
 
 
Growthannually 21.09%
 
 
 
 
 
 

Sales

Growthquarterly -27.30%
 
 
 
 
 
 
Growthannually 133.25%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.